drugset
drugset / Trial / NCT05124275

Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Presbyopia

NCT05124275 ↗

Phase 2 Completed 123 enrolled Glaukos Corporation
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a Multicenter, Randomized, Double-Masked Placebo-Controlled, Parallel Group Phase 2 Trial Evaluating the Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Presbyopia.

Timeline

Start
2022-01-03
Primary completion
2022-09-06
Completion
2022-09-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Pilocarpine Unknown — Topical

Indications

presbyopia